Literature DB >> 11283093

The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg-->Leu mutation at codon 463 of katG are not associated.

H R van Doorn1, E J Kuijper, A van der Ende, A G Welten, D van Soolingen, P E de Haas, J Dankert.   

Abstract

A mutation (CCG-->CTG [Arg-->Leu]) in codon 463 of katG (catalase peroxidase) of Mycobacterium tuberculosis has been found in isoniazid (INH)-resistant strains. A PCR restriction endonuclease analysis to detect this mutation was applied to 395 M. tuberculosis isolates from patients in The Netherlands. The proportion of isolates with a detectable mutation was 32% (32 out of 100) and 29% (85 out of 295) among INH-susceptible isolates and INH-resistant or -intermediate isolates, respectively. Sequencing of five INH-susceptible isolates with such mutations showed that all five had the Arg463Leu mutation. We conclude that the Arg463Leu mutation of katG of M. tuberculosis is not a reliable indicator of INH resistance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11283093      PMCID: PMC87976          DOI: 10.1128/JCM.39.4.1591-1594.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa.

Authors:  W H Haas; K Schilke; J Brand; B Amthor; K Weyer; P B Fourie; G Bretzel; V Sticht-Groh; H J Bremer
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

2.  Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods.

Authors:  I Nachamkin; C Kang; M P Weinstein
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

3.  New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains.

Authors:  M Ristow; M Möhlig; M Rifai; H Schatz; K Feldmann; A Pfeiffer
Journal:  Lancet       Date:  1995-08-19       Impact factor: 79.321

4.  Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands.

Authors:  D van Soolingen; P E de Haas; H R van Doorn; E Kuijper; H Rinder; M W Borgdorff
Journal:  J Infect Dis       Date:  2000-10-26       Impact factor: 5.226

5.  The emergence of drug-resistant tuberculosis in New York City.

Authors:  T R Frieden; T Sterling; A Pablos-Mendez; J O Kilburn; G M Cauthen; S W Dooley
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

6.  Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.

Authors:  B Heym; N Honoré; C Truffot-Pernot; A Banerjee; C Schurra; W R Jacobs; J D van Embden; J H Grosset; S T Cole
Journal:  Lancet       Date:  1994-07-30       Impact factor: 79.321

7.  Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.

Authors:  J M Musser; V Kapur; D L Williams; B N Kreiswirth; D van Soolingen; J D van Embden
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

8.  Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City.

Authors:  M Y Stoeckle; L Guan; N Riegler; I Weitzman; B Kreiswirth; J Kornblum; F Laraque; L W Riley
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

9.  The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.

Authors:  Y Zhang; B Heym; B Allen; D Young; S Cole
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

10.  Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance.

Authors:  F R Cockerill; J R Uhl; Z Temesgen; Y Zhang; L Stockman; G D Roberts; D L Williams; B C Kline
Journal:  J Infect Dis       Date:  1995-01       Impact factor: 5.226

View more
  18 in total

1.  Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil.

Authors:  Rosilene Fressatti Cardoso; Robert C Cooksey; Glenn P Morlock; Patricia Barco; Leticia Cecon; Francisco Forestiero; Clarice Q F Leite; Daisy N Sato; Maria de Lourdes Shikama; Elsa M Mamizuka; Rosario D C Hirata; Mario H Hirata
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  Systematic molecular characterization of multidrug-resistant Mycobacterium tuberculosis complex isolates from Spain.

Authors:  S Samper; M J Iglesias; M J Rabanaque; L I Gómez; M C Lafoz; M S Jiménez; A Ortega; M A Lezcano; D Van Soolingen; C Martín
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

3.  Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China.

Authors:  Min Zhang; Jun Yue; Yan-Ping Yang; Hong-Mei Zhang; Jian-Qiang Lei; Rui-Liang Jin; Xue-Lian Zhang; Hong-Hai Wang
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis.

Authors:  Ann S G Lee; Siti Noor Khadijah Othman; Yu Min Ho; Sin Yew Wong
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

5.  Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan.

Authors:  Chiyoji Abe; Ikuo Kobayashi; Satoshi Mitarai; Masako Wada; Yoshiko Kawabe; Tetsuya Takashima; Katsuhiro Suzuki; Li-Hwei Sng; Suxing Wang; Hla Hla Htay; Hideo Ogata
Journal:  J Clin Microbiol       Date:  2008-05-28       Impact factor: 5.948

6.  Mutations in catalase-peroxidase KatG from isoniazid resistant Mycobacterium tuberculosis clinical isolates: insights from molecular dynamics simulations.

Authors:  Arethusa Lobo Pimentel; Regiane Bertin de Lima Scodro; Katiany Rizzieri Caleffi-Ferracioli; Vera Lúcia Dias Siqueira; Paula Aline Zanetti Campanerut-Sá; Luciana Dias Ghiraldi Lopes; Aryadne Larissa de Almeida; Rosilene Fressatti Cardoso; Flavio Augusto Vicente Seixas
Journal:  J Mol Model       Date:  2017-03-16       Impact factor: 1.810

7.  Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance.

Authors:  Florence Brossier; Nicolas Veziris; Chantal Truffot-Pernot; Vincent Jarlier; Wladimir Sougakoff
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

8.  Detection of multidrug resistance in Mycobacterium tuberculosis.

Authors:  Jun-ichiro Sekiguchi; Tohru Miyoshi-Akiyama; Ewa Augustynowicz-Kopeć; Zofia Zwolska; Fumiko Kirikae; Emiko Toyota; Intetsu Kobayashi; Koji Morita; Koichiro Kudo; Seiya Kato; Tadatoshi Kuratsuji; Toru Mori; Teruo Kirikae
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

9.  Single-nucleotide polymorphism in two representative multidrug-resistant Mycobacterium bovis isolates collected from patients in a Spanish hospital harboring a human infection outbreak.

Authors:  Beatriz Romero; Alicia Aranaz; Javier Bezos; Julio Alvarez; Lucía de Juan; Ana Mateos; Enrique Gómez-Mampaso; Lucas Domínguez
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

10.  Deciphering an outbreak of drug-resistant Mycobacterium tuberculosis.

Authors:  Ulf R Dahle; Per Sandven; Einar Heldal; Turid Mannsaaker; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.